.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
Cerilliant
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Cantor Fitzgerald
Julphar
Chubb
Express Scripts

Generated: November 22, 2017

DrugPatentWatch Database Preview

CYCLOPENTOLATE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for cyclopentolate hydrochloride and what is the scope of cyclopentolate hydrochloride patent protection?

Cyclopentolate hydrochloride
is the generic ingredient in six branded drugs marketed by Novartis Pharms Corp, Akorn Inc, Pharmafair, Sola Barnes Hind, Akorn, Alcon Pharms Ltd, and Bausch And Lomb, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cyclopentolate hydrochloride. Seven suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for CYCLOPENTOLATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084863-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC089162-001Jan 24, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Sola Barnes Hind
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084150-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
AK-PENTOLATE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC085555-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084109-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084110-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
PENTOLAIR
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC040075-001Apr 29, 1994ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
CYCLOPENTOLATE HYDROCHLORIDE
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC205937-001Dec 9, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
CYCLOGYL
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC084108-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Pharmafair
PENTOLAIR
cyclopentolate hydrochloride
SOLUTION/DROPS;OPHTHALMIC088150-001Feb 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Chubb
UBS
McKinsey
Queensland Health
Baxter
Novartis
US Army
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot